These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16827400)

  • 1. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.
    Beaulac JA; Fry RN; Onysko J
    Can J Public Health; 2006; 97(3):171-6. PubMed ID: 16827400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
    Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
    J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
    Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
    J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and cancer screening in older American Indian and Alaska Native men.
    Muus KJ; Baker-Demaray T; McDonald LR; Ludtke RL; Allery AJ; Bogart TA; Goldberg J; Ramsey SD; Buchwald DS
    J Rural Health; 2009; 25(1):104-8. PubMed ID: 19166569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared decision making in prostate-specific antigen testing with men older than 70 years.
    Li J; Berkowitz Z; Richards TB; Richardson LC
    J Am Board Fam Med; 2013; 26(4):401-8. PubMed ID: 23833155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital.
    Dean LT; Subramanian SV; Williams DR; Armstrong K; Zubrinsky Charles C; Kawachi I
    Am J Mens Health; 2015 Sep; 9(5):385-96. PubMed ID: 25117538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of follow-up of prostate-specific antigen test results.
    McFall SL; Smith DW
    Public Health Rep; 2009; 124(5):718-25. PubMed ID: 19753950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
    Williams N; Hughes LJ; Turner EL; Donovan JL; Hamdy FC; Neal DE; Martin RM; Metcalfe C
    BJU Int; 2011 Nov; 108(9):1402-8. PubMed ID: 21481132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.